Is Lenacapavir available in China?

Lenacapavir (Lenacapavir) is not marketed in China. However, the availability of drugs may change over time. Please check the China National Medical Products Administration (NMPA) or relevant pharmaceutical news at any time for the latest information.

Lenacapavir is a revolutionary antiviral drug used to treat HIV (HIV) infection. It belongs to a new class of drugs called HIV reverse transcriptase inhibitors, which can inhibit the replication and spread of the HIV virus. The development of this drug represents a major advance in HIV treatment, especially for patients who have developed resistance to existing treatments.

In China, the marketing of drugs requires a strict approval process, including clinical trials, safety and effectiveness assessments, etc. Once approved and licensed, a drug can be sold and used on the market. Therefore, whether lenakapavir can be marketed in China will depend on the decision of the relevant regulatory authorities and whether the manufacturer meets all necessary regulations and requirements.

China is paying increasing attention to people infected with HIV, and the government and medical institutions are constantly improving HIV treatment and prevention measures. Therefore, if lenakapavir is proven to perform well in clinical trials and meets Chinese national standards and regulations, it is expected to see it launched on the Chinese market in the future.

Lenacapavir has not yet been launched in China, and it is not included in medical insurance. Patients cannot purchase it domestically and need to purchase lenakapavir through overseas channels. There are only original drugs abroad, which are relatively expensive. The American version of the original drug costs about 10,000 yuan.